GENOME THERAPEUTICS CORP
POS AM, EX-23.2, 2000-06-19
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: GENOME THERAPEUTICS CORP, POS AM, 2000-06-19
Next: SUSQUEHANNA BANCSHARES INC, 424B3, 2000-06-19



<PAGE>
                                                                    EXHIBIT 23.2

                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

    As independent public accountants, we hereby consent to the incorporation by
reference of our reports (and to all references to our Firm) included in or made
a part of this registration statement.

                                          /s/ Arthur Andersen LLP

Boston, Massachusetts
June 16, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission